<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Anderson CA</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NCRR NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>Medical Research Council</funding><funding>Chief Scientist Office</funding><funding>Wellcome Trust</funding><funding>Crohn's and Colitis UK</funding><pagination>246-52</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3084597</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>43(3)</volume><pubmed_abstract>Genome-wide association studies and candidate gene studies in ulcerative colitis have identified 18 susceptibility loci. We conducted a meta-analysis of six ulcerative colitis genome-wide association study datasets, comprising 6,687 cases and 19,718 controls, and followed up the top association signals in 9,628 cases and 12,917 controls. We identified 29 additional risk loci (P &lt; 5 × 10(-8)), increasing the number of ulcerative colitis-associated loci to 47. After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1. The total number of confirmed inflammatory bowel disease risk loci is now 99, including a minimum of 28 shared association signals between Crohn's disease and ulcerative colitis.</pubmed_abstract><journal>Nature genetics</journal><pubmed_title>Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.</pubmed_title><pmcid>PMC3084597</pmcid><funding_grant_id>U01 DK062431</funding_grant_id><funding_grant_id>DK076984</funding_grant_id><funding_grant_id>G0800759</funding_grant_id><funding_grant_id>DK062413</funding_grant_id><funding_grant_id>R01 AI062773</funding_grant_id><funding_grant_id>G0800675</funding_grant_id><funding_grant_id>U01 DK062432</funding_grant_id><funding_grant_id>WT091745/Z/10/Z</funding_grant_id><funding_grant_id>U01 DK062429</funding_grant_id><funding_grant_id>P01-DK046763</funding_grant_id><funding_grant_id>DK 063491</funding_grant_id><funding_grant_id>N01HC75150</funding_grant_id><funding_grant_id>U01 DK062420</funding_grant_id><funding_grant_id>083948/Z/07/Z</funding_grant_id><funding_grant_id>CZB/4/540</funding_grant_id><funding_grant_id>WT089120/Z/09/Z</funding_grant_id><funding_grant_id>DK064869</funding_grant_id><funding_grant_id>UL1 TR000005</funding_grant_id><funding_grant_id>U01 DK062423</funding_grant_id><funding_grant_id>U01 DK062422</funding_grant_id><funding_grant_id>R01 DK064869-08</funding_grant_id><funding_grant_id>G0600329</funding_grant_id><funding_grant_id>DK069513</funding_grant_id><funding_grant_id>R01 DK064869-07</funding_grant_id><funding_grant_id>M01 RR000425</funding_grant_id><funding_grant_id>N01HC85079</funding_grant_id><funding_grant_id>P30 DK063491</funding_grant_id><funding_grant_id>U01 DK062432-10</funding_grant_id><funding_grant_id>R01 DK083756</funding_grant_id><funding_grant_id>G1002033</funding_grant_id><funding_grant_id>AI062773</funding_grant_id><funding_grant_id>M11-1</funding_grant_id><funding_grant_id>DK83756</funding_grant_id><funding_grant_id>U01 HL080295</funding_grant_id><funding_grant_id>U01 DK062413</funding_grant_id><funding_grant_id>R01 DK064869-05S1</funding_grant_id><funding_grant_id>DK062431</funding_grant_id><funding_grant_id>DK062432</funding_grant_id><funding_grant_id>U01 DK062432-09</funding_grant_id><funding_grant_id>U01 DK062432-07</funding_grant_id><funding_grant_id>N01 HC035129</funding_grant_id><funding_grant_id>U01 DK062432-08</funding_grant_id><funding_grant_id>R21 DK084554</funding_grant_id><funding_grant_id>P30 DK040561</funding_grant_id><funding_grant_id>P01 DK046763</funding_grant_id><funding_grant_id>M01-RR00425</funding_grant_id><funding_grant_id>P30 DK043351</funding_grant_id><funding_grant_id>R01 HL087652</funding_grant_id><funding_grant_id>R01 DK060049</funding_grant_id><funding_grant_id>R01 DK064869</funding_grant_id><funding_grant_id>R01 DK064869-06A1</funding_grant_id><funding_grant_id>N01 HC015103</funding_grant_id><funding_grant_id>DK043351</funding_grant_id><funding_grant_id>DK062429</funding_grant_id><funding_grant_id>DK062423</funding_grant_id><funding_grant_id>N01HC55222</funding_grant_id><funding_grant_id>DK062420</funding_grant_id><funding_grant_id>DK062422</funding_grant_id><funding_grant_id>P30 DK040561-15</funding_grant_id><funding_grant_id>DK084554</funding_grant_id><funding_grant_id>K23 DK069513</funding_grant_id><funding_grant_id>R03 DK076984</funding_grant_id><pubmed_authors>Gazouli M</pubmed_authors><pubmed_authors>Guthery SL</pubmed_authors><pubmed_authors>Milla M</pubmed_authors><pubmed_authors>Walters T</pubmed_authors><pubmed_authors>Torkvist L</pubmed_authors><pubmed_authors>Sans M</pubmed_authors><pubmed_authors>Kugathasan S</pubmed_authors><pubmed_authors>Satsangi J</pubmed_authors><pubmed_authors>Mathew CG</pubmed_authors><pubmed_authors>Schreiber S</pubmed_authors><pubmed_authors>Anderson CA</pubmed_authors><pubmed_authors>Zhao ZZ</pubmed_authors><pubmed_authors>De Vos M</pubmed_authors><pubmed_authors>Sventoraityte J</pubmed_authors><pubmed_authors>McGovern DP</pubmed_authors><pubmed_authors>Duerr RH</pubmed_authors><pubmed_authors>Goyette P</pubmed_authors><pubmed_authors>Levine A</pubmed_authors><pubmed_authors>Glas J</pubmed_authors><pubmed_authors>Fehrmann RS</pubmed_authors><pubmed_authors>Amininejad L</pubmed_authors><pubmed_authors>Karlsen TH</pubmed_authors><pubmed_authors>Weersma RK</pubmed_authors><pubmed_authors>Russell R</pubmed_authors><pubmed_authors>Floyd JA</pubmed_authors><pubmed_authors>Ponsioen CY</pubmed_authors><pubmed_authors>Vatn M</pubmed_authors><pubmed_authors>Newman W</pubmed_authors><pubmed_authors>Halfvarson J</pubmed_authors><pubmed_authors>Franke L</pubmed_authors><pubmed_authors>Daly MJ</pubmed_authors><pubmed_authors>D'Amato M</pubmed_authors><pubmed_authors>Franke A</pubmed_authors><pubmed_authors>Palmieri O</pubmed_authors><pubmed_authors>Wilson DC</pubmed_authors><pubmed_authors>Baldassano RN</pubmed_authors><pubmed_authors>Libioulle C</pubmed_authors><pubmed_authors>Edwards C</pubmed_authors><pubmed_authors>Parkes M</pubmed_authors><pubmed_authors>Latiano A</pubmed_authors><pubmed_authors>Lawrance I</pubmed_authors><pubmed_authors>Kupcinskas L</pubmed_authors><pubmed_authors>Lees CW</pubmed_authors><pubmed_authors>Vermeire S</pubmed_authors><pubmed_authors>Annese V</pubmed_authors><pubmed_authors>Taylor KD</pubmed_authors><pubmed_authors>Franchimont D</pubmed_authors><pubmed_authors>Lemann M</pubmed_authors><pubmed_authors>Chamaillard M</pubmed_authors><pubmed_authors>Louis E</pubmed_authors><pubmed_authors>Hayward NK</pubmed_authors><pubmed_authors>Hugot JP</pubmed_authors><pubmed_authors>Xavier RJ</pubmed_authors><pubmed_authors>Bayless TM</pubmed_authors><pubmed_authors>Targan SR</pubmed_authors><pubmed_authors>Mowat C</pubmed_authors><pubmed_authors>Florin T</pubmed_authors><pubmed_authors>Boucher G</pubmed_authors><pubmed_authors>Papi L</pubmed_authors><pubmed_authors>Wijmenga C</pubmed_authors><pubmed_authors>Simms LA</pubmed_authors><pubmed_authors>Prescott NJ</pubmed_authors><pubmed_authors>Rioux JD</pubmed_authors><pubmed_authors>Lee JC</pubmed_authors><pubmed_authors>van den Berg LH</pubmed_authors><pubmed_authors>Rotter JI</pubmed_authors><pubmed_authors>Roberts R</pubmed_authors><pubmed_authors>Proctor DD</pubmed_authors><pubmed_authors>Ahmad T</pubmed_authors><pubmed_authors>Georges M</pubmed_authors><pubmed_authors>Anagnou NP</pubmed_authors><pubmed_authors>Andersen V</pubmed_authors><pubmed_authors>Barclay M</pubmed_authors><pubmed_authors>Denson LA</pubmed_authors><pubmed_authors>Mansfield JC</pubmed_authors><pubmed_authors>Seibold F</pubmed_authors><pubmed_authors>Morley KI</pubmed_authors><pubmed_authors>Ng A</pubmed_authors><pubmed_authors>Gearry R</pubmed_authors><pubmed_authors>Jobin G</pubmed_authors><pubmed_authors>Silverberg MS</pubmed_authors><pubmed_authors>Ophoff RA</pubmed_authors><pubmed_authors>Barrett JC</pubmed_authors><pubmed_authors>Steinhart AH</pubmed_authors><pubmed_authors>Hakonarson H</pubmed_authors><pubmed_authors>Brand S</pubmed_authors><pubmed_authors>Radford-Smith G</pubmed_authors><pubmed_authors>Laukens D</pubmed_authors><pubmed_authors>Sanderson J</pubmed_authors><pubmed_authors>Sharma Y</pubmed_authors><pubmed_authors>Imielinski M</pubmed_authors><pubmed_authors>Dubinsky M</pubmed_authors><pubmed_authors>Haritunians T</pubmed_authors><pubmed_authors>Colombel JF</pubmed_authors><pubmed_authors>Westra HJ</pubmed_authors><pubmed_authors>Peyrin-Biroulet L</pubmed_authors><pubmed_authors>Verspaget H</pubmed_authors><pubmed_authors>Cho JH</pubmed_authors><pubmed_authors>Scott R</pubmed_authors><pubmed_authors>Phillips A</pubmed_authors><pubmed_authors>Griffiths AM</pubmed_authors><pubmed_authors>Panes J</pubmed_authors><pubmed_authors>Montgomery GW</pubmed_authors><pubmed_authors>Lagace C</pubmed_authors><pubmed_authors>Baidoo L</pubmed_authors><pubmed_authors>Ellinghaus D</pubmed_authors><pubmed_authors>Schumm P</pubmed_authors><pubmed_authors>Bumpstead S</pubmed_authors><pubmed_authors>Rutgeerts P</pubmed_authors><pubmed_authors>Brant SR</pubmed_authors><pubmed_authors>Seielstad M</pubmed_authors><pubmed_authors>Glazer NL</pubmed_authors><pubmed_authors>Buning C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.</name><description>Genome-wide association studies and candidate gene studies in ulcerative colitis have identified 18 susceptibility loci. We conducted a meta-analysis of six ulcerative colitis genome-wide association study datasets, comprising 6,687 cases and 19,718 controls, and followed up the top association signals in 9,628 cases and 12,917 controls. We identified 29 additional risk loci (P &lt; 5 × 10(-8)), increasing the number of ulcerative colitis-associated loci to 47. After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1. The total number of confirmed inflammatory bowel disease risk loci is now 99, including a minimum of 28 shared association signals between Crohn's disease and ulcerative colitis.</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Mar</publication><modification>2021-02-19T23:27:53Z</modification><creation>2019-03-27T00:41:04Z</creation></dates><accession>S-EPMC3084597</accession><cross_references><pubmed>21297633</pubmed><doi>10.1038/ng.764</doi></cross_references></HashMap>